Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, L.
Right arrow Articles by Speck, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, L.
Right arrow Articles by Speck, O.
Neurology 2000;54:389
© 2000 American Academy of Neurology


Articles

Perfusion MRI detects rCBF abnormalities in early stages of HIV–cognitive motor complex

Linda Chang, MD, Thomas Ernst, PhD, Maria Leonido-Yee, MD and Oliver Speck, PhD

From the Departments of Neurology (Drs. Chang, Ernst, Leonido-Yee, and Speck) and Radiology (Dr. Ernst), Harbor-UCLA Medical Center, Torrance, CA.

Address correspondence and reprint requests to Dr. Linda Chang, Harbor-UCLA Medical Center, Department of Neurology, 1124 West Carson Street, B-4, Torrance, CA 90502.

OBJECTIVE: To evaluate patients with early HIV–cognitive motor complex (HIV-CMC) for possible regional cerebral blood flow (rCBF) abnormalities on perfusion MRI (pMRI).

BACKGROUND: Nuclear medicine techniques have demonstrated global and focal cerebral perfusion abnormalities in patients with HIV dementia. Ultrafast pMRI enables the measurement of rCBF throughout the brain without the need to apply radioactive tracers or ionizing radiation.

METHODS: pMRI was used to measure the rCBF in 19 patients with early stages of HIV-CMC and 15 healthy seronegative control subjects. The rCBF maps were registered to high-resolution anatomic MRI scans and transformed into Talairach space. Statistical analysis of the rCBF maps was performed with SPM96.

RESULTS: Compared with the control subjects, the patients with HIV had statistically significantly decreased rCBF bilaterally in the inferior lateral frontal cortices (right: -15%, p < 0.002; left: -12%, p < 0.005) and in the inferior medial parietal brain region (-15%, p < 0.0009). In contrast, rCBF was increased bilaterally in the posterior inferior parietal white matter (right: +19%, p < 0.0001; left: +17%, p < 0.001). Furthermore, rCBF abnormalities correlated significantly with clinical disease severity as measured by CD4 count, plasma viral load, Karnofsky score, and HIV dementia scale.

DISCUSSION: Our results are consistent with previous findings from PET and SPECT studies. Furthermore, pMRI can detect rCBF abnormalities that correlate with disease severity in HIV-CMC. Because pMRI is more cost-effective, faster, and safer than nuclear medicine techniques for monitoring rCBF changes, pMRI may be more feasible for monitoring the effects of therapy for HIV-CMC.

Key words: Brain—HIV dementia—Perfusion—MRI




This article has been cited by other articles:


Home page
Arch NeurolHome page
M. G. Pomper and N. Sacktor
New Techniques for Imaging Human Immunodeficiency Virus Associated Cognitive Impairment in the Era of Highly Active Antiretroviral Therapy
Arch Neurol, September 1, 2007; 64(9): 1233 - 1235.
[Full Text] [PDF]


Home page
NeurologyHome page
B. M. Ances, A. C. Roc, J. Wang, M. Korczykowski, J. Okawa, J. Stern, J. Kim, R. Wolf, K. Lawler, D. L. Kolson, et al.
Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients
Neurology, March 28, 2006; 66(6): 862 - 866.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
Y. Ge, M. Law, G. Johnson, J. Herbert, J. S. Babb, L. J. Mannon, and R. I. Grossman
Dynamic Susceptibility Contrast Perfusion MR Imaging of Multiple Sclerosis Lesions: Characterizing Hemodynamic Impairment and Inflammatory Activity
AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1539 - 1547.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
F. Wenserski, H.-J. von Giesen, H.-J. Wittsack, A. Aulich, and G. Arendt
Human Immmunodeficiency Virus 1-associated Minor Motor Disorders: Perfusion-weighted MR Imaging and H MR Spectroscopy
Radiology, July 1, 2003; 228(1): 185 - 192.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Ernst, L. Chang, J. Jovicich, N. Ames, and S. Arnold
Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients
Neurology, November 12, 2002; 59(9): 1343 - 1349.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. Chang, O. Speck, E. N. Miller, J. Braun, J. Jovicich, C. Koch, L. Itti, and T. Ernst
Neural correlates of attention and working memory deficits in HIV patients
Neurology, September 25, 2001; 57(6): 1001 - 1007.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
R. I. HERNING, W. E. BETTER, K. TATE, and J. L. CADET
Antiviral Medications Improve Cerebrovascular Perfusion in HIV+ Non-Drug Users and HIV+ Cocaine Abusers
Ann. N.Y. Acad. Sci., June 1, 2001; 939(1): 405 - 412.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.